Close Menu

Nazneen Rahman has figured out a way to make genetic testing more easily accessible for UK women with ovarian cancer, writes Ed Yong at the Atlantic. Women with BRCA1 or BRCA2 mutations are more likely to respond to certain chemotherapy drugs and PARP inhibitors, but getting tested can be difficult.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.